| Patent | Date |
|---|
Pharmaceutical products
Grant 10,092,519 - Oshlack , et al. October 9, 2 | 2018-10-09 |
Pharmaceutical Products
App 20150366811 - OSHLACK; Benjamin ; et al. | 2015-12-24 |
Pharmaceutical product comprising a sequestered agent
Grant 9,149,436 - Oshlack , et al. October 6, 2 | 2015-10-06 |
Controlled Release Oxycodone Compositions
App 20130012533 - Oshlack; Benjamin ; et al. | 2013-01-10 |
Controlled Release Oxycodone Compositions
App 20130011543 - Oshlack; Benjamin ; et al. | 2013-01-10 |
Melt-extruded Orally Administrable Opioid Formulations
App 20100172974 - Oshlack; Benjamin ; et al. | 2010-07-08 |
Controlled Release Oxycodone Compositions
App 20100092570 - Oshlack; Benjamin ; et al. | 2010-04-15 |
Controlled Release Oxycodone Compositions
App 20100034876 - Oshlack; Benjamin ; et al. | 2010-02-11 |
Melt-extrusion Multiparticulates
App 20090148517 - Oshlack; Benjamin ; et al. | 2009-06-11 |
Melt-extrusion multiparticulates
Grant 7,510,727 - Oshlack , et al. March 31, 2 | 2009-03-31 |
Orally Adminstrable Opioid Formulations Having Extended Duration Of Effect
App 20090068269 - Oshlack; Benjamin ; et al. | 2009-03-12 |
Orally Administrable Opioid Formulations Having Extended Duration Of Effect
App 20080181941 - Oshlack; Benjamin ; et al. | 2008-07-31 |
Controlled release oxycodone compositions
App 20080075781 - Oshlack; Benjamin ; et al. | 2008-03-27 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
App 20080063712 - Oshlack; Benjamin ; et al. | 2008-03-13 |
Orally Administrable Opioid Formulations Having Extended Duration Of Effect
App 20080044482 - Oshlack; Benjamin ; et al. | 2008-02-21 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 7,316,821 - Oshlack , et al. January 8, 2 | 2008-01-08 |
Controlled release oxycodone compositions
App 20070275062 - Oshlack; Benjamin ; et al. | 2007-11-29 |
Controlled release oxycodone compositions
App 20070275065 - Oshlack; Benjamin ; et al. | 2007-11-29 |
Orally administrable opioid formulations having extended duration of effect
Grant 7,270,831 - Oshlack , et al. September 18, 2 | 2007-09-18 |
Controlled release oxycodone compositions
App 20060165791 - Oshlack; Benjamin ; et al. | 2006-07-27 |
Controlled release oxycodone compositions
App 20060165792 - Oshlack; Benjamin ; et al. | 2006-07-27 |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
Grant 7,070,806 - Oshlack , et al. July 4, 2 | 2006-07-04 |
Controlled release oxycodone compositions
App 20060099255 - Oshlack; Benjamin ; et al. | 2006-05-11 |
Controlled release oxycodone compositions
App 20060057210 - Oshlack; Benjamin ; et al. | 2006-03-16 |
Formulations and methods for providing prolonged local anesthesia
Grant 6,921,541 - Chasin , et al. July 26, 2 | 2005-07-26 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 6,905,709 - Oshlack , et al. June 14, 2 | 2005-06-14 |
Melt-extruded orally administrable opioid formulations
App 20050089568 - Oshlack, Benjamin ; et al. | 2005-04-28 |
Pharmaceutical products
App 20040228924 - Oshlack, Benjamin ; et al. | 2004-11-18 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
App 20040228917 - Oshlack, Benjamin ; et al. | 2004-11-18 |
Methods of administering opioid antagonists and compositions thereof
App 20040192715 - Chasin, Mark ; et al. | 2004-09-30 |
Controlled release oxycodone compositions
App 20040185098 - Oshlack, Benjamin ; et al. | 2004-09-23 |
Melt-extrusion multiparticulates
App 20040185096 - Oshlack, Benjamin ; et al. | 2004-09-23 |
Orally adminstrable opioid formulations having extended duration of effect
App 20040121001 - Oshlack, Benjamin ; et al. | 2004-06-24 |
Controlled release oxycodone compositions
App 20040105887 - Oshlack, Benjamin ; et al. | 2004-06-03 |
Melt-extruded orally administrable opioid formulations
Grant 6,743,442 - Oshlack , et al. June 1, 2 | 2004-06-01 |
Controlled release oxycodone compositions
App 20040096500 - Oshlack, Benjamin ; et al. | 2004-05-20 |
Melt-extruded orally administrable opioid formulations
App 20040081694 - Oshlack, Benjamin ; et al. | 2004-04-29 |
Melt-extrusion multiparticulates
Grant 6,706,281 - Oshlack , et al. March 16, 2 | 2004-03-16 |
Methods for providing safe local anesthesia
Grant 6,699,908 - Sackler , et al. March 2, 2 | 2004-03-02 |
Stabilized sustained release tramadol formulations
Grant 6,645,527 - Oshlack , et al. November 11, 2 | 2003-11-11 |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
App 20030198673 - Oshlack, Benjamin ; et al. | 2003-10-23 |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
App 20030190358 - Oshlack, Benjamin ; et al. | 2003-10-09 |
Formulations and methods for providing prolonged local anesthesia
App 20030185873 - Chasin, Mark ; et al. | 2003-10-02 |
Orally administrable opioid formulations having extended duration of effect
App 20030180361 - Oshlack, Benjamin ; et al. | 2003-09-25 |
Prolonged anesthesia in joints and body spaces
App 20030175357 - Goldenhim, Paul ; et al. | 2003-09-18 |
Local anesthetic, and method of use
App 20030152637 - Chasin, Mark ; et al. | 2003-08-14 |
Sustained release oxycodone formulations with no fed/fast effect
App 20030129231 - Oshlack, Benjamin ; et al. | 2003-07-10 |
Orally administrable opioid formulations having extended duration of effect
Grant 6,572,885 - Oshlack , et al. June 3, 2 | 2003-06-03 |
Controlled release oxycodone compositions
App 20030099704 - Oshlack, Benjamin ; et al. | 2003-05-29 |
Purine compounds having PDE IV inhibitory activity and methods of synthesis
App 20030073834 - Cavalla, David J. ; et al. | 2003-04-17 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
App 20030054032 - Oshlack, Benjamin ; et al. | 2003-03-20 |
Prolonged anesthesia in joints and body spaces
Grant 6,534,081 - Goldenheim , et al. March 18, 2 | 2003-03-18 |
Formulations and methods for providing prolonged local anesthesia
Grant 6,524,607 - Goldenheim , et al. February 25, 2 | 2003-02-25 |
Formulations and methods for providing prolonged local anesthesia
Grant 6,521,259 - Chasin , et al. February 18, 2 | 2003-02-18 |
Melt-extrusion multiparticulates
App 20030026839 - Oshlack, Benjamin ; et al. | 2003-02-06 |
Formulations and methods for providing prolonged local anesthesia
Grant 6,514,516 - Chasin , et al. February 4, 2 | 2003-02-04 |
Formulations and methods for providing prolonged local anesthesia
Grant 6,451,335 - Goldenheim , et al. September 17, 2 | 2002-09-17 |
Methods for providing safe local anesthesia
App 20020114835 - Sackler, Richard S. ; et al. | 2002-08-22 |
Sustained release oxycodone formulations with no fed/fast effect
App 20020102303 - Oshlack, Benjamin ; et al. | 2002-08-01 |
Stabilized sustained release tramadol formulations
App 20020102302 - Oshlack, Benjamin ; et al. | 2002-08-01 |
Orally administrable opioid formulations having extended duration of effect
App 20020081333 - Oshlack, Benjamin ; et al. | 2002-06-27 |
Immediate release tablet cores of insoluble drugs having sustained-release coating
Grant 6,387,404 - Oshlack , et al. May 14, 2 | 2002-05-14 |
Prolonged anesthesia in joints and body spaces
App 20020054915 - Goldenheim, Paul ; et al. | 2002-05-09 |
Benzoxazoles
Grant 6,372,770 - Chasin , et al. April 16, 2 | 2002-04-16 |
Controlled release oxycodone compositions
App 20020018810 - Oshlack, Benjamin ; et al. | 2002-02-14 |
Sustained Release Hydromorphone Formulations Exhibiting Bimodal Characteristics
App 20020006438 - OSHLACK, BENJAMIN ; et al. | 2002-01-17 |
Melt-extrusion multiparticulates
Grant 6,335,033 - Oshlack , et al. January 1, 2 | 2002-01-01 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 6,316,031 - Oshlack , et al. November 13, 2 | 2001-11-13 |
Melt-extruded orally administrable opioid formulations
App 20010036476 - Oshlack, Benjamin ; et al. | 2001-11-01 |
Melt-extrusion Multiparticulates
App 20010033865 - OSHLACK, BENJAMIN ; et al. | 2001-10-25 |
Stabilized sustained release tramadol formulations
Grant 6,306,438 - Oshlack , et al. October 23, 2 | 2001-10-23 |
Sustained release oxycodone formulations with no fed/fast effect
App 20010031278 - Oshlack, Benjamin ; et al. | 2001-10-18 |
Immediate release tablet cores of insoluble drugs having sustained-release coating
App 20010026809 - Oshlack, Benjamin ; et al. | 2001-10-04 |
Purine derivatives having phosphodiesterase IV inhibition activity
Grant 6,294,541 - Cavalla , et al. September 25, 2 | 2001-09-25 |
Orally administrable opioid formulations having extended duration of effect
Grant 6,294,195 - Oshlack , et al. September 25, 2 | 2001-09-25 |
Controlled release oxycodone compositions
App 20010008639 - Oshlack, Benjamin ; et al. | 2001-07-19 |
Melt-extruded orally administrable opioid formulations
Grant 6,261,599 - Oshlack , et al. July 17, 2 | 2001-07-17 |
Phenyl-triazole compounds for PDE-IV inhibition
Grant 6,248,769 - Cavalla , et al. June 19, 2 | 2001-06-19 |
Prolonged anesthesia in joints and body spaces
Grant 6,248,345 - Goldenheim , et al. June 19, 2 | 2001-06-19 |
Purine derivatives having phosphodiesterase IV inhibition activity
Grant 6,228,859 - Cavalla , et al. May 8, 2 | 2001-05-08 |
Immediate release tablet cores of acetaminophen having sustained-release coating
Grant 6,210,714 - Oshlack , et al. April 3, 2 | 2001-04-03 |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
Grant 6,166,041 - Cavalla , et al. December 26, 2 | 2000-12-26 |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
Grant 6,143,353 - Oshlack , et al. November 7, 2 | 2000-11-07 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 6,129,933 - Oshlack , et al. October 10, 2 | 2000-10-10 |
Aryl imidazole compounds having phosphodiesterase IV inhibitory activity
Grant 6,103,749 - Cavalla , et al. August 15, 2 | 2000-08-15 |
Opioid formulations having extended controlled release
Grant 6,103,261 - Chasin , et al. August 15, 2 | 2000-08-15 |
Purine compounds having PDE IV inhibitory activity and methods of synthesis
Grant 6,040,447 - Cavalla , et al. March 21, 2 | 2000-03-21 |
Trisubstituted thioxanthines
Grant 6,025,361 - Cavalla , et al. February 15, 2 | 2000-02-15 |
Immediate release tablet cores of insoluble drugs having sustained-release coating
Grant 6,024,982 - Oshlack , et al. February 15, 2 | 2000-02-15 |
Orally administrable opioid formulations having extended duration of effect
Grant 5,968,551 - Oshlack , et al. October 19, 1 | 1999-10-19 |
Extruded multi-particulates
Grant 5,965,161 - Oshlack , et al. October 12, 1 | 1999-10-12 |
Extruded orally administrable opioid formulations
Grant 5,958,452 - Oshlack , et al. September 28, 1 | 1999-09-28 |
Opioid formulations having extended controlled released
Grant 5,958,459 - Chasin , et al. September 28, 1 | 1999-09-28 |
Formulations and methods for providing prolonged local anesthesia
Grant 5,942,241 - Chasin , et al. August 24, 1 | 1999-08-24 |
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
Grant 5,922,751 - Cavalla , et al. July 13, 1 | 1999-07-13 |
Heterocyclic compounds for inhibiting phosphodiesterase IV
Grant 5,889,014 - Cavalla , et al. March 30, 1 | 1999-03-30 |
Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
Grant 5,864,037 - Chasin , et al. January 26, 1 | 1999-01-26 |
Prolonged local anesthesia with colchicine
Grant 5,747,060 - Sackler , et al. May 5, 1 | 1998-05-05 |
Emollient antimicrobial formulations containing povidone iodine
Grant 5,716,611 - Oshlack , et al. February 10, 1 | 1998-02-10 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 5,681,585 - Oshlack , et al. October 28, 1 | 1997-10-28 |
Controlled release oxycodone compositions
Grant 5,656,295 - Oshlack , et al. August 12, 1 | 1997-08-12 |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
Grant 5,639,476 - Oshlack , et al. June 17, 1 | 1997-06-17 |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
Grant 5,580,578 - Oshlack , et al. December 3, 1 | 1996-12-03 |
Controlled release oxycodone compositions
Grant 5,549,912 - Oshlack , et al. August 27, 1 | 1996-08-27 |
Controlled release oxycodone compositions
Grant 5,508,042 - Oshlack , et al. April 16, 1 | 1996-04-16 |
Immediate release tablet cores of insoluble drugs having sustained-release coating
Grant 5,500,227 - Oshlack , et al. March 19, 1 | 1996-03-19 |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
Grant 5,472,712 - Oshlack , et al. * December 5, 1 | 1995-12-05 |
Controlled release coatings derived from aqueous dispersions of zein
Grant 5,356,467 - Oshlack , et al. October 18, 1 | 1994-10-18 |
Aqueous dispersions of zein and preparation thereof
Grant 5,324,351 - Oshlack , et al. June 28, 1 | 1994-06-28 |
Stabilized controlled release formulations having acrylic polymer coating
Grant 5,286,493 - Oshlack , et al. February 15, 1 | 1994-02-15 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Grant 5,273,760 - Oshlack , et al. December 28, 1 | 1993-12-28 |
Controlled release oxycodone compositions
Grant 5,266,331 - Oshlack , et al. * November 30, 1 | 1993-11-30 |
Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
Grant 5,122,367 - Ron , et al. June 16, 1 | 1992-06-16 |
| 